LRCX.US Weekly Report · 2026-W41
This week Lam Research faces a disconnect between valuation and fundamentals: P/E stands near the 3-year low percentile, earnings growth exceeds 40%, and institutions overwhelmingly favor the stock, yet institutional capital flowed outward and the stock price fell 2.2%. Short-term selling pressure collides with medium-term demand support as the market awaits next week’s earnings call and further confirmation of AI infrastructure momentum.
Price Action
Weekly close at $318.84, down 2.20% from Monday’s opening at $326.00. Intraweek high $326.72, low $316.01, range 3.29%. Trading volume 4.655M shares, turnover rate 37%.
The price trajectory shows a classic high-open, continuous selloff pattern: a 0.22% gap-up on Monday followed by relentless downside. Pre-market Friday rallied to $325.71 but failed to hold, closing below $318 again. After-hours trading extended losses to $318.51.
Valuation Position
P/E of 54.92x sits at approximately the 5.8th percentile over the past three years—meaning 94% of trading days saw higher P/E ratios. This is near historical bottom. However, relative to the industry median of 43.42x, current P/E remains ~13% elevated. This paradox reveals the dual nature: relatively undervalued against the company’s own history, but absolutely expensive versus the sector.
P/B of 31.99x remains elevated, reflecting the valuation premium attached to exceptional return-on-equity (ROE near 80%).
Earnings Delivery
Latest Quarter (Q4 2026): EPS $1.812, YoY +34.8%; operating revenue $6.722B, YoY +29.99%; net profit $2.277B, YoY +32.39%; net margin 33.88%.
Sequential Trends: Six consecutive quarters have maintained earnings growth above 30%. Q4 shows a modest deceleration in EPS growth (40.78% in Q3 vs. 34.8% in Q4), though still robust. Profitability quality improved, with net margin expanding from 29.46% in Q1 to 33.88% in Q4.
vs. Consensus: Consensus EPS forecast stands at $9.475 (likely full-year). Summing the four latest quarters ($1.812+$1.45+$1.26+$1.24 = $5.76) suggests that if full-year consensus is $9.475, the market is pricing in continued acceleration or a different forecast period. Current disclosed results remain solid.
Capital Flow
As of October 9, institutional capital showed clear outflows: large-cap inflows $49.82B, outflows $311.93B, net outflow $261B; mid-cap inflows $226.04B, outflows $306.58B, net outflow $80.54B. Retail investors moved counter-cyclically: inflows $882.71B, outflows $862.75B, net inflow ~$20B.
Signal Divergence: Heavy institutional selling colliding with retail buying strength suggests money managers are either locking in gains or repositioning, while retail sees a buying opportunity. This bifurcation often appears at inflection points where risk and opportunity overlap.
Institutional View
35 covering analysts: 29 rate buy or strong buy (25 strong buy, 4 buy), 6 hold, 0 sell. Industry rank 3/36, indicating the highest consensus among peers. Consensus price target $375.65, implying 17.8% upside; range $290–$500.
Latest major rating updates on October 5 (report date), so ratings retain relative timeliness. Important caveat: ratings lag market pricing and should not be treated as short-term verdict, but longer-term direction carries weight.
Weekly Narrative
Market focus has centered on two themes:
1. AI Capex Momentum Persists
Bank of America named Lam Research as one of five semiconductor equipment stocks worth holding in Q4; Morgan Stanley projects December quarter revenue guidance will exceed $9B, setting a new record high. These calls reinforce that data center AI investment appetite remains strong.
2. Earnings & Rating Dynamics
Over the past week, multiple analyst upgrades and positive commentary have contrasted sharply with the stock’s price decline. Management has scheduled the earnings call, which typically serves as a key forum to reset expectations and address industry concerns.
Key News Links (reverse chronological):
- Cramer’s week ahead: Earnings kick off as banks and chipmakers face big tests
- Jim Cramer Calls Kulicke & Soffa ‘Terrific,’ But Prefers These 2 Chip Equipment Stocks
- Lam Research Corp. Stock Outperforms Competitors Despite Losses On The Day
- Hot Pre-Market Trades in US Stocks: Lam Research Down 3.11%; ASML Down 3.03%
- Morgan Stanley expects Lam Research to guide $9B-plus for December quarter
- BofA Names ‘5 AI Chip Stocks’ to Buy in Q4 as AI Spending Stays Strong
- Weekly Recap | Lam Research +10.24%, consensus target above spot
- Lam Research (NASDAQ:LRCX) Stock Price Up 3.5% on Analyst Upgrade
- Lam Research Corp Stock (LRCX) Moved Up by 3.01% on Oct 1: Key Drivers Unveiled
- Top 5 Semiconductor Stocks to Own Into Year End: Bank of America
Summary
Fundamentals and capital flows are pulling in opposite directions. Earnings momentum, industry demand, and analyst consensus all point to upside, while valuation sits near historic lows—yet institutional net outflows and a 2.2% weekly decline signal caution. The market may be booking profits, viewing near-term AI demand as fully priced, or simply awaiting next week’s guidance call for confirmation of sustained capex intensity.
Retail net buying at these levels suggests floor support emerging. Whether institutional selling will abate depends on management’s ability to affirm undiminished AI spending next week. This is a key inflection point worth monitoring.